Isracann Biosciences Inc.

    Isracann Biosciences Inc.

    CCSE:IPOT
    - -
    CAD
    - -
    - -
    Isracann Biosciences Inc.
    CSE:IPOT
    (Canadian Securities Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    TTM
    CAD
    - -
    - -
    - -
    - -
    0.01
    0.03
    0.06
    0.05
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    -0.07
    -0.03
    -0.04
    -0.04
    -0.15
    -0.09
    -0.12
    -0.33
    -0.25
    -0.26
    -0.18
    -0.03
    -0.03
    Basic EPS, GAAP
    -0.07
    -0.03
    -0.04
    -0.04
    -0.18
    -0.03
    -0.1
    -0.39
    -0.08
    -0.12
    -0.03
    -0.01
    -0.01
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    0.16
    0.13
    0.1
    0.06
    0.19
    0.11
    0.01
    0.36
    0.4
    0.2
    0.03
    - -
    - -
    Book Value per Share
    0.16
    0.13
    0.1
    0.06
    0.09
    0.05
    0.01
    0.36
    0.4
    0.04
    0.03
    -0.02
    -0.02
    Tangible Book Value per Share
    2
    2
    2
    2
    4
    6
    6
    23
    38
    93
    138
    148
    150
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    -1,531.75
    -232.98
    -171.06
    -535.45
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    -1
    - -
    -1
    -7
    -10
    -24
    -25
    -5
    -5
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    -1,531.75
    -261.34
    -207.76
    -636.91
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    8
    14
    4
    2
    -1
    -1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    1
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    1
    1
    - -
    14
    15
    27
    4
    - -
    - -
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    -21.16
    -36.52
    -54.62
    -99.9
    -59.1
    -195.82
    -108.79
    -66.21
    -115.54
    -164.97
    -221.78
    -252.29
    Return on Common Equity (%)

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Feb'22
    May'22
    Aug'23
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    146
    158
    163
    Market Capitalization
    15
    11
    7

    Working Capital

    CAD

    •

    in mil. unless spec.
    Feb'22
    May'22
    Aug'23
    Total Current Assets
    1
    - -
    - -
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    1
    1
    1
    Payables & Accruals
    1
    1
    1
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    1,693.93%
    3,292.51%
    -92.62%
    Free Cash Flow
    248.6%
    307.4%
    -58.65%
    Net Income, GAAP
    166.09%
    224.35%
    -81.34%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    -0.01
    -0.01
    - -
    -0.18
    2022
    - -
    -0.01
    - -
    - -
    -0.03
    2023
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business